 |
|
|
|
|
|
|
Important Notice: The ADDF/ISOA and Alzheimer Research Forum do not endorse any company or product, and listing in this directory is not linked to corporate sponsorship. We do not make a claim to being comprehensive or up to date. If you would like to recommend a company to be listed in the database, please contact us.
|
|
|
 |
|
|
|
|
|
|
ABGENT
Website: Abgent Website and Protein Modification Resource
Company/Resource Category: Reagents, Services, In vitro, Cell-based, In vivo, Proteins/Enzymes, Receptors, Discovery, Development, Screening, Chemistry, Biologicals, Antibodies, Diagnostic
Profile:
Abgent develops powerful tools to profile posttranslational modifications related to cellular function and disease. Abgent antibodies offer the most extensive coverage targeting protein kinases, phosphatases, methyl and acetyl transferases, ubiquitin and SUMO, glycosylases and other protein modification enzymes. Our mission is to accelerate research and discovery by targeting post-translational modifications that dynamically regulate protein function, and to thereby accelerate understanding of the complex path leading from cell signaling to pathology.
Abgent's innovative products and custom services for the study of proteomic modifications rank us as a selected supplier in Natures 2003 Antibody Technology and 2004 Drug Discovery Features and in The Scientist's 2003 Cell Signaling and 2004 Phosphorylation Features.
|
|
|
|
|
Home
